-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Alnylam Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2016 to 2023.
- Alnylam Pharmaceuticals, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $611M, a 11.4% increase year-over-year.
- Alnylam Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $2.24B, a 8.63% increase year-over-year.
- Alnylam Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $2.11B, a 15.8% increase from 2022.
- Alnylam Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $1.82B, a 17.4% increase from 2021.
- Alnylam Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $1.55B, a 17.5% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)